Diogo Martins-Branco - Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB)

基本信息

Career Trajectory

Bio

Specialist in medical oncology and palliative care, passionate about clinical research. Areas of interest: breast cancer, immuno-oncology, clinical research methodology, RWE, public health, epidemiology, palliative and supportive care. Traveler, who loves to play tennis and ski.

Research Interests

Papers共 51 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Impact of Erythropoiesis-Stimulating Agents Administration Concomitantly with Adjuvant Anti-Her2 Treatments on the Outcomes of Patients with Early Breast Cancer: a Sub-Analysis of the ALTTO Study

Diogo Martins-Branco,Marie Kassapian,Véronique Debien,Rafael Caparica,Daniel Eiger,Urania Dafni,Charitini Andriakopoulou,Sarra El-Abed,Susan L. Ellard,Miguel Izquierdo,Malou Vicente,Saranya Chumsri,Martine Piccart-Gebhart,Alvaro Moreno-Aspitia,Ann Søegaard Knop,Janine Lombard,Evandro de Azambuja

BREAST CANCER RESEARCH AND TREATMENTno. 3 (2024): 497-509

Cited0Views0Bibtex

Real-world Evidence Reported for Clinical Efficacy Evaluation in European Public Assessment Reports of Authorised Targeted Therapies for Solid Malignancies: a Comprehensive Review (2018-2022)

J.W.G. Derksen,D. Martins-Branco,A. Valachis,A. Pellat,S.C.M.W. van Nassau, A. Aggarwal,G. Pentheroudakis,M. Koopman,L. Castelo-Branco,S. Delaloge

ESMO Real World Data and Digital Oncology (2024): 100039

Cited0Views0Bibtex

Abstract PS17-04: Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches

Cancer Researchno. 9_Supplement (2024): PS17-04

Cited0Views0Bibtex

Abstract GS01-03: Adding Atezolizumab to Adjuvant Chemotherapy for Stage II and III Triple-Negative Breast Cancer is Unlikely to Improve Efficacy: Interim Analysis of the ALEXANDRA/IMpassion030 Phase 3 Trial

Michail Ignatiadis,Andrew Bailey,Heather McArthur,Sarra El-Abed,Evandro de Azambuja,Otto Metzger, Steve Chui, Max Dieterich, Thomas Perretti,Guenther Steger,Jacek Jassem,Soo Chin Lee,Michaela Higgins, José Zarbá,Marcus Schmidt,Henry Gomez,Angel Guerrero-Zotano,Luca Moscetti,Joanne Win Yang Chiu,Carter DuFrane,Vanessa Honvault, Rosa Altarcheh,Luciana Molinero, Andrew Ellingson,Elisabetta Munzone,Noa Efrat Ben-Baruch,Emilio Bajetta,Shinji Ohno,Seock-Ah Im,Gustavo Werutsky,Einav Gal-Yam,Xavier Gonzalez-Farré,Ling-Ming Tseng,William Jacot,Oleg Gluz,Zhimin Shao,Yaroslav Shparyk, Ivan Sinielnikov,Zimina Anastasia, Aleksandr Vasiliev, Esther Shearer-Kang,Eric Winer,Diogo Martins-Branco,Shona Fielding,David Cameron,Giuseppe Viale,Shigehira Saji,Richard Gelber,Martine Piccart

Cancer Researchno. 9_Supplement (2024): GS01-03

Cited0Views0Bibtex

Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancer

Francois Cherifi,Angelique Da Silva,Diogo Martins-Branco,Ahmad Awada,Guilherme Nader-Marta

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGYno. 1-2 (2024): 45-59

Cited0Views0WOSBibtex

Pharmacokinetics and Pharmacodynamics of Antibody-Drug Conjugates for the Treatment of Patients with Breast Cancer

François Cherifi,Angélique Da Silva,Diogo Martins-Branco,Ahmad Awada,Guilherme Nader Marta

Expert opinion on drug metabolism & toxicologyno. 1-2 (2024): 45-59

Cited0Views0Bibtex

Surgery of the Primary Tumor in Patients with De Novo Metastatic Breast Cancer: a Nationwide Population-Based Retrospective Cohort Study in Belgium

Diogo Martins-Branco,Mariana Brandão,Evandro de Azambuja

BREAST CANCER RESEARCH AND TREATMENTno. 2 (2024): 351-363

Cited0Views0WOSBibtex

Abstract CT202: CSFctDNA As a Surrogate for Tumor Tissue DNA in BC Pts with CNS Metastases: First Results from the Brainstorm Program (oncodistinct 006)

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

The Impact of Initial Tumor Response on Survival Outcomes of Patients with HER2-positive Advanced Breast Cancer Treated with Docetaxel, Trastuzumab, and Pertuzumab: an Exploratory Analysis of the CLEOPATRA Trial

Veronique Debien,Elisa Agostinetto,Marco Bruzzone,Marcello Ceppi,Diogo Martins-Branco,Chiara Molinelli,Flavia Jacobs,Guilherme Nader-Marta,Matteo Lambertini,Evandro de Azambuja

CLINICAL BREAST CANCERno. 5 (2024)

Cited0Views0WOSBibtex

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a Tool for Assessing Tumour-Agnostic Potential of Molecularly Guided Therapies and for Steering Drug Development

C.B. Westphalen,D. Martins-Branco,J.R. Beal, C. Cardone, N. Coleman,A.M. Schram, S. Halabi,S. Michiels,C. Yap, F. André, F. Bibeau,G. Curigliano,E. Garralda,S. Kummar,R. Kurzrock,S. Limaye, S. Loges,A. Marabelle,C. Marchió, J. Mateo

Annals of Oncology (2024)

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn